Results

Total Results: over 10,000 records

Showing results for "drugs".

41. New Data Visualization Shows Use of Drugs in 2014-2018 Later Prescribed for COVID-19 | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/data-visualization-use-drugs.html
    January 01, 2022 - New Data Visualization Shows Use of Drugs in 2014-2018 Later Prescribed for COVID-19 A … albuterol, the antibiotic azithromycin, and the steroid prednisone, were the three most commonly used drugs … before the COVID-19 pandemic among the drugs later used to treat COVID-19. … Quantifying the use and expenditures of these medications before COVID-19 suggests how the drugs’ new … uses may cause shortages or price increases that affect people who were using these drugs prior to the

42. Retail and Mail Order Drugs Used in 2014-18 and Later Prescribed For COVID-19 | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/data/visualizations/retail-drugs-covid-19.html
    January 01, 2022 - Home Data & Analytics Data Visualizations Retail and Mail Order Drugs … ’ new uses may cause shortages or price increases that affect people who used these drugs before the … Source: AHRQ MEPS Research Findings #49: Pre-COVID-19 Retail Use and Expenditures for Drugs That Were … This information is used to present the percent distribution of conditions associated with drugs that … https://www.ahrq.gov/data/visualizations/retail-drugs-covid-19.html  

43. Final Progress Report: Off-Label Prescribing: Comparative Evidence, Regulation, and Utilization (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/kesselheim-report.pdf
    January 01, 2024 - , neuropsychiatric drugs, and drugs for other rare diseases. … Second, I identified selected drugs in three target categories—neuropsychiatric drugs, oncologic drugs … , and drugs for other rare diseases. … orphan drugs and found that off-label uses predominate in orphan drugs used for popular “symptoms” … Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower

44. Paramedics turn to expired drugs due to shortages. | PSNet
    psnet.ahrq.gov/issue/paramedics-turn-expired-drugs-due-shortages
    September 05, 2012 - Newspaper/Magazine Article Paramedics turn to expired drugs due to shortages. … Citation Text: Paramedics turn to expired drugs due to shortages. WBUR. August 8, 2012. … Cite Citation Citation Text: Paramedics turn to expired drugs … July 5, 2023 Nearly all thirty most frequently used emergency department drugs experienced … September 12, 2016 Despite federal legislation, shortages of drugs used in acute care

45. 2003 Prescribed Drug Estimates: Top Prescribed Drugs by Total Expenditures
    meps.ahrq.gov/data_stats/summ_tables/hc/drugs/2003/hcdrugest_totexp2003.shtml
    January 01, 2003 - 2003 Prescribed Drug Estimates: Top Prescribed Drugs by Total Expenditures …     Prescribed Drug Estimates: 2003 Table 1.1 Top Prescribed Drugs … 2,103,096,705 4,675,609 Standard Errors for Table 1.1: Top Prescribed Drugs

46. Audit of missed or delayed antimicrobial drugs. | PSNet
    psnet.ahrq.gov/issue/audit-missed-or-delayed-antimicrobial-drugs
    August 01, 2012 - Newspaper/Magazine Article Audit of missed or delayed antimicrobial drugs. … Citation Text: Audit of missed or delayed antimicrobial drugs. Wright J. … Cite Citation Citation Text: Audit of missed or delayed antimicrobial drugs

47. Characteristics of medication errors with parenteral cytotoxic drugs. | PSNet
    psnet.ahrq.gov/issue/characteristics-medication-errors-parenteral-cytotoxic-drugs
    July 01, 2017 - Study Characteristics of medication errors with parenteral cytotoxic drugs. … Characteristics of medication errors with parenteral cytotoxic drugs. … Characteristics of medication errors with parenteral cytotoxic drugs. … May 27, 2011 Computerized physician order entry of injectable antineoplastic drugs: an

48. Tamper-resistant drugs cannot solve the opioid crisis. | PSNet
    psnet.ahrq.gov/issue/tamper-resistant-drugs-cannot-solve-opioid-crisis
    May 01, 2019 - Commentary Tamper-resistant drugs cannot solve the opioid crisis. … Tamper-resistant drugs cannot solve the opioid crisis. … Tamper-resistant drugs cannot solve the opioid crisis.

49. Novel Role for Adiponectin-enhancing Drugs for Asthma in the Obese (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/sood-r01grant.pdf
    January 31, 2016 - Novel Role for Adiponectin-enhancing Drugs for Asthma in the Obese Rapid Secondary Analysis to Optimize … Patients with Multiple Chronic Conditions – R01 Grants Novel Role for Adiponectin-enhancing Drugs … Examine the role that anti-adiponectin drugs have on asthma. 2. … Examine the role that anti-adiponectin drugs have on depression or ischemic cardiovascular disease. … Examine the effect of gender on the effect of anti-adiponectin drugs on above diseases.

50. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization-cost
    August 26, 2011 - Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Timeline August 26, 2011 Topic Initiated August 26, 2011 Research Report Data Points #6: Utilization and cost of anticancer biologic products among M…

51. Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. | PSNet
    psnet.ahrq.gov/issue/using-drug-knowledgebase-information-distinguish-between-look-alike-sound-alike-drugs
    July 10, 2019 - Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs … Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. … Look-alike, sound-alike drugs are a known safety risk and contribute to medication errors . … Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. … March 23, 2016 Look alike/sound alike drugs: a literature review on causes and solutions

52. S13 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Unique Problems in the Study of Pharmaceuticals Exposure misclassification is a unique challenge in … Indeed, the confounders of concern are usually other drugs or other diseases. … In addition, studies of pharmaceuticals, especially stud- ies of the effectiveness of pharmaceuticals … CONCLUSIONS The goal of our research community is to optimize the use of pharmaceuticals by improving

53. S13 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Unique Problems in the Study of Pharmaceuticals Exposure misclassification is a unique challenge in … Indeed, the confounders of concern are usually other drugs or other diseases. … In addition, studies of pharmaceuticals, especially stud- ies of the effectiveness of pharmaceuticals … CONCLUSIONS The goal of our research community is to optimize the use of pharmaceuticals by improving

54. Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018 (pdf file)
    meps.ahrq.gov/data_files/publications/st532/stat532.pdf
    December 01, 2020 - drugs have led to concerns about high, and rising, out-of- pocket costs for prescription drugs. … Among those who used prescription drugs, we examine the distribution of out-of-pocket spending for drugs … drugs. … Definitions Prescribed drugs Only prescribed drugs obtained from retail pharmacies, including mail … Note: Among people who obtained retail prescribed drugs.

55. Final Progress Report: Off-Label Prescribing: Comparative Evidence, Regulation, and Utilization (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/18465-Kesselheim-draft-1.pdf
    January 01, 2015 - , neuropsychiatric drugs, and drugs for other rare diseases. … Second, I identified selected drugs in three target categories—neuropsychiatric drugs, oncologic drugs … , and drugs for other rare diseases. … orphan drugs and found that off-label uses predominate in orphan drugs used for popular “symptoms” … Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower

56. Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal detection analysis using a database of spontaneously reported adverse events (FAERS). | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/drugs
    January 01, 2023 - Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal … Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal

57. Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps
    January 01, 2005 - Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs … Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs

58. STATISTICAL BRIEF #532: Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018
    meps.ahrq.gov/data_files/publications/st532/stat532.shtml
    December 01, 2020 - prescription drugs. … Among those who used prescription drugs, we examine the distribution of out-of-pocket spending for drugs … In 2018, half of uninsured people who obtained prescribed drugs spent $55 or less annually on their drugs … Definitions Prescribed drugs Only prescribed drugs obtained from retail pharmacies, including … Note: Among people who obtained retail prescribed drugs.

59. Reducing Adverse Drug Events Related to Anticoagulant Use in Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/high-risk-drugs/rapid-research
    January 01, 2024 - Project Timeline Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events … https://effectivehealthcare.ahrq.gov/products/high-risk-drugs/rapid-research  

60. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cancer-drugs-utilization-cost/research
    December 01, 2019 - Drugs used in the treatment of cancer account for a large share of Medicare Part B drug expenditures. … Two of these drugs, rituximab and bevacizumab, are biologics. … Using 2006 data, the Centers for Medicare & Medicaid Services (CMS) reported on the top 100 Part D drugs … https://effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization-cost/research